Prof Mark Shackleton is the Director of Oncology at Alfred Health, a Professor of Oncology at Monash University, a Co-Director of the Monash Partners Comprehensive Cancer Consortium, and the Chair of Melanoma and Skin Cancer Trials Ltd.. After training in medical oncology at the Ludwig Institute in Melbourne, he undertook PhD studies at the Walter and Eliza Hall Institute of Medical Research and postdoctoral work at the University of Michigan, USA. He has received several major prizes for his research: the 2006 Victorian Premier’s Award for Medical Research, a 2010 NHMRC Achievement Award, a 2011 Pfizer Australia Fellowship, and a 2016 Victorian Cancer Agency Clinical Research Fellowship. In 2012, he was awarded the Australian Science Minister’s Prize for Life Scientist of the Year. His clinical interests include cutaneous oncology, melanoma, molecular oncology, immuno-oncology, early phase clinical trials, and addressing inequities in health service delivery. His laboratory studies melanocyte biology and the causes and consequences of cancer heterogeneity.